About
John Clarkson is the Board Member at ReadyGo Diagnostics. He has been in healthcare and diagnostics businesses for the past 15 years and has a background in molecular biology. He co-founded Molecular Sensing plc in 1999 where he was Commercial Director and then Technical Director. Following the successful development of their DNA analysis system, he joined the US-based diagnostics company Osmetech plc when they acquired Molecular in 2004. John led the formation of Atlas Genetics in 2005 as a joint spin-out from the University of Bath and Osmetech plc. Atlas is developing rapid tests for infectious diseases such as the sexually transmitted infections Chlamydia and gonorrhea, and hospital acquired infections. The company is VC backed and raised £18.5m in 2011 in a series B financing round led by Novartis Venture Funds.
Position in the VCSift Database
- • 243 investors hold the Board Member role in VCSift. John Clarkson is one of them.
- • 2 investors are based in Trowbridge, Wiltshire, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Trowbridge, UK
Contact Information
Find more investors like John
Search Investors